EGFR
Clinical trials for EGFR explained in plain language.
Never miss a new study
Get alerted when new EGFR trials appear
Sign up with your email to follow new studies for EGFR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control OngoingThis study tests a new drug called TT125-802 in about 50 adults with advanced solid tumors (like lung cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also look at whether the drug ca…
Matched conditions: EGFR
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
Lung cancer clue: could a DNA glitch guide future treatments?
Knowledge-focused OngoingThis study examines whether a specific DNA repair problem, called homologous recombination deficiency (HRD), is common in a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will analyze tumor samples from 100 patients to see if HRD is linked to how the cance…
Matched conditions: EGFR
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC